GPBAR1 Knockout SK-N-AS Cell Line
Cat.No.:
EDC07743
Species:
Human
Cell Name:
SK-N-AS
Gene:
GPBAR1
Gene ID:
151306
Size:
1×10⁶cells
GPBAR1 Knockout SK-N-AS Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07743 |
|---|---|
| Product Name | GPBAR1 Knockout SK-N-AS Cell Line |
| Species | Human |
| Cell Line | SK-N-AS |
| Cellosaurus ID | CVCL_1700 |
| Gene ID | |
| Cell Line Synonyms | SKN-AS, SKNAS |
| Gene | GPBAR1 |
| Summary |
This gene encodes a member of the G protein-coupled receptor (GPCR) superfamily. This enzyme functions as a cell surface receptor for bile acids. Treatment of cells expressing this GPCR with bile acids induces the production of intracellular cAMP, activation of a MAP kinase signaling pathway, and internalization of the receptor. The receptor is implicated in the suppression of macrophage functions and regulation of energy homeostasis by bile acids. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Neuroblastoma |
| Digestion Time | 3 min |
| Morphology | Adherent |
| Passage Ratio | 1:3 |
| Complete Culture Medium | DMEM+10% FBS+1% NEAA |
| Freezing Medium | 90% FBS+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: SK-N-AS | STR Info (Cell bank) Cell Line: SK-N-AS | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 10 | 12 | 10 | 12 |
| D2S1338 | 17 | 24 | 17 | 24 |
| D3S1358 | 14 | 14 | ||
| D5S818 | 11 | 12 | 11 | 12 |
| D7S820 | 11 | 13 | 11 | 13 |
| D8S1179 | 13 | 14 | 13 | 14 |
| D13S317 | 9 | 9 | ||
| D16S539 | 14 | 14 | ||
| D18S51 | 14 | 15 | 14 | 15 |
| D19S433 | 12 | 14 | 12 | 14 |
| D21S11 | 32.2 | 33.2 | 32.2 | 33.2 |
| FGA | 20 | 22 | 20 | 22 |
| Penta D | 9 | 9 | ||
| Penta E | 7 | 14 | 7 | 14 |
| TH01 | 9.3 | 9.3 | ||
| TPOX | 11 | 12 | 11 | 12 |
| vWA | 16 | 17 | 16 | 17 |
| D6S1043 | 11 | 12 | ||
| D12S391 | 20 | 24 | ||
| D2S441 | 11 | |||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying GPBAR1 function, GPBAR1 Knockout SK-N-AS Cell Line or GPBAR1 overexpression SK-N-AS Cell Line?
The choice depends on whether you are studying GPBAR1 (TGR5, M-BAR)'s role as the principal bile acid-sensing GPCR or its emerging functions in neural and metabolic biology. The Knockout line is the standard tool for asking whether TGR5 is required for these processes — GPBAR1/TGR5 is a Gs-coupled seven-transmembrane receptor activated by bile acids (particularly lithocholic acid, taurolithocholic acid, deoxycholic acid), with established roles in energy metabolism, glucose homeostasis, and emerging functions in cancer and CNS biology. Overexpression is useful for studying TGR5 in heterologous expression contexts.
For TGR5 research, the EDITGENE GPBAR1 Knockout in SK-N-AS enables study of TGR5 biology — SK-N-AS is a non-MYCN-amplified neuroblastoma cell line providing a neural-derived background. Rescue with wild-type or signaling-deficient TGR5 enables structure-function studies. The knockout is a critical specificity control for TGR5 agonists (INT-777, cilofexor for cholestatic liver disease, semaglutide-related bile acid pharmacology) and emerging TGR5-targeted metabolic disease therapeutics.
What are the application scenarios for this model?
Primary applications:
• Bile acid-induced signaling: cAMP elevation following lithocholic acid, taurolithocholic acid, or other TGR5 agonist stimulation in TGR5-null cells.
• Neural TGR5 biology: in heterologous neural contexts, characterization of TGR5's emerging CNS functions.
• TGR5 agonist specificity: critical genetic control for INT-777 (TGR5 agonist) and other emerging TGR5-targeting compounds.
• Bile acid signaling crosstalk: parallel analysis with FXR signaling for understanding the FXR-TGR5 dual bile acid signaling axis.
EDITGENE recommends this neuroblastoma-derived model for researchers investigating TGR5 biology in neural contexts and bile acid signaling biology.
Is this GPBAR1 Knockout SK-N-AS Cell Line compatible with overexpression rescue experiments?
Yes. TGR5 rescue experiments require attention to bile acid binding:
• Construct design: use a codon-modified GPBAR1 sequence with a small intracellular C-terminal tag (FLAG, HA). GPBAR1 is a seven-transmembrane Gs-coupled GPCR — preserve bile acid-binding pocket.
• Signaling-deficient rescue: DRY motif mutations disrupt Gs-coupling.
• Functional readout: rescue should restore bile acid-induced cAMP elevation and downstream PKA signaling.
SK-N-AS-specific considerations:
• SK-N-AS is a human neuroblastoma cell line (non-MYCN-amplified, derived from bone marrow metastasis) — a relevant model for non-MYCN-amplified neuroblastoma biology.
• Lentiviral transduction is supported with moderate efficiency.
• SK-N-AS provides a neural-derived background distinct from MYCN-amplified neuroblastoma lines.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download